# Sublingual Methadone for the Management of Cancer-related Procedure Pain in Inpatients

> **NCT00351637** · PHASE2 · TERMINATED · sponsor: **Alberta Health services** · enrollment: 60 (estimated)

## Conditions studied

- Cancer
- Pain

## Interventions

- **DRUG:** Sublingual Methadone

## Key facts

- **NCT ID:** NCT00351637
- **Lead sponsor:** Alberta Health services
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-12
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 60 (ESTIMATED)
- **Why stopped:** Study suspended due to low accrual
- **Last updated:** 2012-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00351637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00351637, "Sublingual Methadone for the Management of Cancer-related Procedure Pain in Inpatients". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00351637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*